ES2143489T3 - Mejoras en radioetiquetado. - Google Patents

Mejoras en radioetiquetado.

Info

Publication number
ES2143489T3
ES2143489T3 ES93302712T ES93302712T ES2143489T3 ES 2143489 T3 ES2143489 T3 ES 2143489T3 ES 93302712 T ES93302712 T ES 93302712T ES 93302712 T ES93302712 T ES 93302712T ES 2143489 T3 ES2143489 T3 ES 2143489T3
Authority
ES
Spain
Prior art keywords
hydroxyalkyl
alkylcarboxy
tetra
hydroxy
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93302712T
Other languages
English (en)
Inventor
Gary James Bridger
Pedro Emilio Hernandez
John David Higgins Iii
Scott Kenneth Larsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anormed Inc
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Application granted granted Critical
Publication of ES2143489T3 publication Critical patent/ES2143489T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Confectionery (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Road Signs Or Road Markings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Casings For Electric Apparatus (AREA)
  • Hydrogenated Pyridines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

SE PRESENTA EL LIGANTE L, (R3)(R4)(R5)C-N(R)-C(R1)(R2)-(CH2)N-COOH L EN DONDE R ES HIDROGENO, HIDROXIDO, ALQUIL, HIDROXIALQUIL, O ALQUILCARBOXIDO, O R Y R1 JUNTAS FORMAN UN RADICAL DE MONO-, DI-, TRIUNTAS UN RADICAL DE MONO-, DI-, TRI R2 PUEDEN SER IGUALES O DIFERENTES Y SE SELECCIONAN ENTRE HIDROGENO, HIDROXIDO, ALQUIL, HIDROXIALQUIL, CARBOXIDO, ALQUILCARBOXIDO, ALQUILAMINO, ALQUILTIOL, ARIL O R1 Y R2 PUEDEN FORMAR JUNTAS UN RADICAL DE TETRA DEN SER IGUALES O DIFERENTES Y SE SELECCIONAN ENTRE HIDROGENO, HIDROXIDO, ALQUIL, HIDROXIALQUIL, CARBOXIDO, ALQUILCARBOXIDO, CON LA CONDICION DE QUE AL MENOS UNA DE ENTRE R3, R4 Y R5 SEA HIDROXIALQUIL, Y N ES 0, 1 O 2, POR EJEMPLO EN FORMA DE TRICINA, QUE FORMA COMPLEJOS UTILES CON 99MTC, PARA LA RADIOETIQUETACION DE MACROMOLECULAS TALES COMO ANTICUERPOS MONOCLONALES.
ES93302712T 1992-05-02 1993-04-07 Mejoras en radioetiquetado. Expired - Lifetime ES2143489T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209641A GB9209641D0 (en) 1992-05-02 1992-05-02 Improvements in radiolabelling

Publications (1)

Publication Number Publication Date
ES2143489T3 true ES2143489T3 (es) 2000-05-16

Family

ID=10714995

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93302712T Expired - Lifetime ES2143489T3 (es) 1992-05-02 1993-04-07 Mejoras en radioetiquetado.

Country Status (19)

Country Link
US (1) US5350837A (es)
EP (1) EP0569132B1 (es)
JP (1) JP3271259B2 (es)
KR (1) KR100293777B1 (es)
AT (1) ATE190063T1 (es)
AU (1) AU663581B2 (es)
CA (1) CA2094380C (es)
DE (1) DE69327914T2 (es)
DK (1) DK0569132T3 (es)
ES (1) ES2143489T3 (es)
FI (1) FI931968A (es)
GB (1) GB9209641D0 (es)
GR (1) GR3033379T3 (es)
HK (1) HK1013828A1 (es)
NO (1) NO306407B1 (es)
NZ (1) NZ247445A (es)
PT (1) PT569132E (es)
TW (1) TW227564B (es)
ZA (1) ZA932844B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
US5744120A (en) 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
US5480970A (en) * 1993-12-22 1996-01-02 Resolution Pharmaceuticals Metal chelators
US5569745A (en) * 1994-02-25 1996-10-29 Resolution Pharmaceuticals Inc. Peptide-Chelator conjugates
ZA955642B (en) * 1994-07-07 1997-05-06 Ortho Pharma Corp Lyophilized imaging agent formulation
US5662885A (en) * 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US5942210A (en) * 1994-11-15 1999-08-24 Cytogen Corporation Methods for lyoprotecting a macromolecule using tricine
US5879659A (en) * 1996-03-13 1999-03-09 Dupont Pharmaceuticals Company Ternary radiopharmaceutical complexes
EP0888130B1 (en) * 1996-03-13 2003-07-02 Bristol-Myers Squibb Pharma Company New ternary radiopharmaceutical complexes
US6416733B1 (en) * 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
US20030124053A1 (en) * 1996-10-07 2003-07-03 Barrett John Andrew Radiopharmaceuticals for imaging infection and inflammation
US6403054B1 (en) * 1997-05-28 2002-06-11 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US6524553B2 (en) * 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
EP1068222A1 (en) 1998-04-03 2001-01-17 Du Pont Pharmaceuticals Company Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer
US6511649B1 (en) * 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
CA2349333A1 (en) * 1998-12-18 2000-06-22 Du Pont Pharmaceuticals Company Vitronectin receptor antagonist pharmaceuticals
US6569402B1 (en) * 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6794518B1 (en) * 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
BR9917079A (pt) 1998-12-18 2001-10-30 Du Pont Pharm Co Compostos antagonistas de receptor devitronectina, kit, composição metalofarmacêuticade diagnóstico ou terapêutica, composição deagente de contraste para ultra-som, composiçãoradiofarmacêutica terapêutica, composiçãofarmacêutica de diagnóstico, método detratamento da artrite reumatóide, do cancêr e darestenose em um paciente, método de formação deimagem da angiogênese terapêutica, do câncer, denovos vasos sanguìneos, da arteriosclerose, darestenose, da isquemia e da lesão por reperfusãodo miocárdio em um paciente
US6346547B1 (en) * 1999-02-08 2002-02-12 Checkpoint, Genetics, Inc. N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith
US6808698B1 (en) 1999-03-26 2004-10-26 Bristol-Myers Squibb Pharma Company Method for localization of blood clots
US6534038B2 (en) 2000-04-07 2003-03-18 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
HUP0400758A3 (en) * 2000-11-03 2005-02-28 Bristol Myers Squibb Pharma Co Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
US6776977B2 (en) 2001-01-09 2004-08-17 Bristol-Myers Squibb Pharma Company Polypodal chelants for metallopharmaceuticals
US6517814B2 (en) 2001-01-09 2003-02-11 Bristol-Myers Squibb Pharma Company Macrocyclic chelants useful for metallopharmaceuticals
AU2002331042B2 (en) * 2001-08-08 2007-10-25 Bristol-Myers Squibb Pharma Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US7317104B2 (en) 2003-06-13 2008-01-08 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US7319149B2 (en) * 2003-06-13 2008-01-15 Bristol-Myers Squibb Pharma Company Chelants and macrocyclic metal complex radiopharmaceuticals thereof
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
KR20080022588A (ko) * 2005-06-30 2008-03-11 브리스톨-마이어스 스퀴브 파마 컴퍼니 영상화제로서의 히드라지드 컨쥬게이트
US7939659B2 (en) * 2008-04-17 2011-05-10 Thomas Daly Biological buffers with wide buffering ranges
US9447310B2 (en) 2008-04-17 2016-09-20 Thomas P. Daly Biological buffers with wide buffering ranges
US8519141B2 (en) 2008-04-17 2013-08-27 Thomas Daly Biological buffers with wide buffering ranges
US8334402B2 (en) 2008-04-17 2012-12-18 Thomas Daly Biological buffers with wide buffering ranges
US20170313920A1 (en) 2010-10-06 2017-11-02 Thomas P. Daly Biological Buffers with Wide Buffering Ranges
US8822728B2 (en) 2008-04-17 2014-09-02 Thomas Daly Biological buffers with wide buffering ranges
US9090638B2 (en) 2008-04-17 2015-07-28 Thomas Daly Biological buffers with wide buffering ranges
US8034951B2 (en) * 2008-04-17 2011-10-11 Thomas Daly Biological buffers with wide buffering ranges
US7635791B2 (en) * 2008-04-17 2009-12-22 Tpat Ip Llc Biological buffers with wide buffering ranges
US9475754B2 (en) 2011-10-06 2016-10-25 Thomas P. Daly Biological buffers with wide buffering ranges

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD118526A5 (es) * 1974-04-30 1976-03-12
US4017596A (en) * 1975-03-03 1977-04-12 Research Corporation Radiopharmaceutical chelates and method of external imaging
US4425280A (en) * 1981-03-30 1984-01-10 Ferro Corporation Metal amino acids
US4772724A (en) * 1986-12-02 1988-09-20 Warner-Lambert Canada Inc. Essentially pure acid hydroxyl ligand aluminum complexes and their preparation
WO1989000557A1 (en) * 1987-07-16 1989-01-26 Cockbain, Julian, Roderick, Michaelson Aminopolycarboxylic acids and derivatives thereof
IL93432A (en) * 1989-02-24 1994-02-27 Johnson Mathey Inc Hydrazines and hydrazides, their conjugates with macromolecules, and such conjugates labeled with metallic ions

Also Published As

Publication number Publication date
HK1013828A1 (en) 1999-09-10
EP0569132B1 (en) 2000-03-01
DK0569132T3 (da) 2000-07-31
GB9209641D0 (en) 1992-06-17
JP3271259B2 (ja) 2002-04-02
DE69327914D1 (de) 2000-04-06
CA2094380C (en) 2002-02-12
NO306407B1 (no) 1999-11-01
TW227564B (es) 1994-08-01
KR930023028A (ko) 1993-12-18
AU3717393A (en) 1993-11-04
ATE190063T1 (de) 2000-03-15
US5350837A (en) 1994-09-27
DE69327914T2 (de) 2000-06-29
NO931585D0 (no) 1993-04-30
PT569132E (pt) 2000-08-31
FI931968A (fi) 1993-11-03
AU663581B2 (en) 1995-10-12
GR3033379T3 (en) 2000-09-29
ZA932844B (en) 1994-06-21
NO931585L (no) 1993-11-03
JPH0665169A (ja) 1994-03-08
KR100293777B1 (ko) 2001-11-22
NZ247445A (en) 1995-07-26
CA2094380A1 (en) 1993-11-03
EP0569132A1 (en) 1993-11-10
FI931968A0 (fi) 1993-04-30

Similar Documents

Publication Publication Date Title
ES2143489T3 (es) Mejoras en radioetiquetado.
ZA911740B (en) Tris-maleimido compounds as intermediates in trifunctional antibody synthesis
ATE248859T1 (de) Metallion-ligand koordinationskomplexe, antikorper dagegen und tests die solche antikorper verwenden
ES226390Y (es) Grapa de cierre en forma de "u" para bolsas.
DE69417970D1 (de) Quelle für schnelle Atomstrahlen
FR2713137B1 (fr) Composants de boîtes en complexe métalloplastique obtenus par emboutissage.
FR2474872B1 (fr) Dispositif d'attache pour ceintures de securite
IL105583A0 (en) Selenium sulfide shampoo with conditioning properties
FR2536660B1 (fr) Fermeture de sangle pour une ceinture de securite
FR2539201B1 (fr) Dispositif d'etancheite pour carter en deux parties longitudinales
FR2536638B1 (fr) Fermeture de ceinture de securite
BR8304925A (pt) Arranjo para travar o dispositivo que desenrola o cinto de seguranca de um veiculo
DK131693D0 (da) Immunoassay for molekyler indeholdende alfa 1-kaeden af det n-terminale propeptid i humant procollagen type i
IT219358Z2 (it) Chiusura di sucurezza per contenitori, in particolare per lattine d'olio
ES1014126Y (es) "dispositivo colocador-accionador de sacos con valvula"
ES1012875Y (es) Cierre practicable para mamparas de bano.
ES265190Y (es) "cierre de seguridad para bolsas y sobres".
ES1013131Y (es) Cierre para maletines.
ES1014642Y (es) Sujecion mejorada para pestillos en cierres embutidos.
BR9002032A (pt) Fecho rapido para fins diversos
BR8307021A (pt) Fecho ajustavel para artigos de vestuario
IE901991L (en) Cysteine thiol-protected peptides for use in immunoassays.
IT9019509A0 (it) Borsa valori con chiusura sovrapposta
IT1138402B (it) Dispositivo di chiusura addizionale di bagagli in genere
BR7000084U (pt) Disposicao introduzida em mecanismo de vedacao

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 569132

Country of ref document: ES